
News|Articles|August 1, 2006
Pipeline Preview (August 2006)
Hepatitis B immune globulin (human) (Nabi-HB, Nabi Bio-pharmaceuticals) for the treatment of hepatitis B infection
Advertisement
Recommendations for approval
Approvable designations
Fast-track designations
Orphan drug designations
Non-approvable designations
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Judi Health, Employers Health team up to launch new PBM solution
3
Deborah Dempsey, Pharm.D., MBA, RPh, on 340B discounts vs. rebates | PBMI 2026
4
Amivantamab, chemo combo shows nearly 3-year survival in EGFR exon 20 lung cancer
5

















